SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Aligos Therapeutics, Inc. – ALGS

NEW YORK, Jan. 7, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Aligos Therapeutics, Inc. (“Aligos” or the “Company”) (NASDAQ: ALGS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…